Extracorporeal photopheresis
Showing 1 - 25 of 1,027
Lung Transplant Infection, Lung Transplant Rejection Trial in Vienna (ECP (Extracorporeal Photopheresis System))
Completed
- Lung Transplant Infection
- Lung Transplant Rejection
- ECP (Extracorporeal Photopheresis System)
-
Vienna, AustriaMedical University Vienna
Jan 31, 2023
COVID-19 Trial in Budapest (Extracorporeal photopheresis)
Recruiting
- COVID-19
- Extracorporeal photopheresis
-
Budapest, HungarySouth Pest Central Hospital, National Institute of Haematology a
May 28, 2023
Photopheresis in GvHD After Hematopoietic Transplantation:
Enrolling by invitation
- Graft Vs Host Disease
- Extracorporeal Photopheresis
- Extracorporeal Photopheresis
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023
Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))
Active, not recruiting
- Chronic Graft-versus-host-disease
- Itacitinib
- Extracorporeal Photopheresis (ECP)
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Jan 30, 2023
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))
Not yet recruiting
- Graft Versus Host Disease
- Allogeneic mesenchymal stromal cells (MSCs)
- Extracorporeal photopheresis (ECP)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022
Extracorporeal Photopheresis in Sezary Syndrome
Recruiting
- Sezary Syndrome
- Extracorporeal photopheresis (ECP)
- Methoxsalen Injection
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Aug 12, 2022
Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)
Not yet recruiting
- Antibody-mediated Rejection
- Lung Transplant Rejection
- Extracorporeal Photopheresis
- (no location specified)
Oct 30, 2023
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
Completed
- Scleroderma, Systemic
- +4 more
-
Berlin, GermanyCharité-Universitätsmedizin Berlin
Nov 16, 2022
Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)
Recruiting
- Type 1 Diabetes
- ECP regular-intensity arm
- +2 more
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
Oct 28, 2022
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Crohn Disease Trial in Lorenskog (5-aminolevulinic acid, Blue light photopheresis, Transfusion)
Recruiting
- Crohn Disease
- 5-aminolevulinic acid
- +4 more
-
Lorenskog, Akershus, NorwayAkershus University Hospital
Mar 8, 2022
Immune-related Adverse Events Refractory to Standard Therapy and
Recruiting
- Immune-related Adverse Event
- Extracorporeal photopheresis
- Other immunosuppressive or immunomodulatory drugs
-
Munich, GermanyLMU Klinikum Hauttumorzentrum
Jan 17, 2023
Kidney Transplant Rejection Trial in Barcelona (Extracorporeal Photopheresis)
Not yet recruiting
- Kidney Transplant Rejection
- Extracorporeal Photopheresis
-
Barcelona, Please Select, SpainDeparment of Nephology and Kidney Transplant
Mar 15, 2022
Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With
Active, not recruiting
- Cutaneous T Cell Lymphoma
- Graft Versus Host Disease
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 31, 2021
Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)
Recruiting
- Immune Related Adverse Events
- +3 more
-
Freiburg, Baden-Württemberg, GermanyMedical Center - University of Freiburg Albert-Ludwigs-Universit
Jun 9, 2022
Extracorporeal Photopheresis as Treatment of Chronic Lung
Active, not recruiting
- Lung Transplant Rejection
- Extracorporeal photopheresis
- (no location specified)
Mar 9, 2021
Dynamic of Immunocompetent Populations in Patients Treated With
Recruiting
- Graft Versus Host Disease
- Extracorporeal Photopheresis
- Blood samples
- skin biopsy
-
Lille, FranceHôpital Claude Huriez, CHU
Nov 18, 2020
GVHD (GVHD) Trial in United States (extracorporeal photopheresis, laboratory biomarker analysis)
Terminated
- Graft Versus Host Disease (GVHD)
- extracorporeal photopheresis
- laboratory biomarker analysis
-
Atlanta, Georgia
- +3 more
Jan 11, 2021
Graft Vs Host Disease Trial in Toronto (Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP),
Recruiting
- Graft Vs Host Disease
- Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP), mTOR inhibitors (everolimus or sirolimus), vedolizumab, ruxolitinib.
- Decidual Stromal Cells
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Feb 3, 2022
ECP Combination Study
Active, not recruiting
- Steroid Refractory GVHD
- Ruxolitinib
- +2 more
-
Antwerp, Belgium
- +37 more
Jun 17, 2022
Chronic Graft vs. Host Disease, GVHD, GVHD Trial run by the NCI (Extracorporeal Photopheresis (ECP), Methoxsalen)
Terminated
- Chronic Graft vs. Host Disease
- +2 more
- Extracorporeal Photopheresis (ECP)
- Methoxsalen
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2020
Cardiac Allograft Vasculopathy, Heart Transplant Rejection Trial in Zagreb (Extracoropreal photopheresis)
Recruiting
- Cardiac Allograft Vasculopathy
- Heart Transplant Rejection
- Extracoropreal photopheresis
-
Zagreb, CroatiaUHC Zagreb
Jan 8, 2020